Table 4.
Odds of post-menopausal women being prescribed gastrointestinal medications after at least 30 days of HRT.
| OR | 95% CI | p-Value | %Risk | |
|---|---|---|---|---|
| PPI | 1.14 | [1.102–1.179] | <0.0001 | 16.421% |
| Prucalopride | 3.765 | [2.422–5.853] | <0.0001 | 0.139% |
| Domperidone | 2.402 | [1.148–5.023] | 0.0163 | 0.035% |
| Metoclopramide | 1.112 | [1.059–1.169] | <0.0001 | 5.487% |
| Antiemetics | 1.21 | [1.176–1.245] | <0.0001 | 29.704% |
PPIs: rabeprazole, lansoprazole, esomeprazole, pantoprazole, omeprazole, dexlansoprazole. Antiemetics, including ondansetron, trimethobenzamide, prochlorperazine. Abbreviations: proton pump inhibitor (PPI), odds ratio (OR), confidence interval (CI), hormone replacement therapy (HRT).